Fool.com
The World's Greatest Investing Community
Results 11 - 20 of 1086 : Previous 1 2 3 4 5 6 7 8 9 Next
A Schizophrenic Move by Merck?
Issue $29 billion in shares, buy back $3 billion. Say what?
The World's Best Dividend Stocks
Don't limit yourself to U.S. blue chips.
Companies You Should Buy Right Now
Don't mess around when it comes to your wealth.
The power of concentration is before our eyes.
The Side Effect of Developing Obesity Drugs
The FDA is fickle when it comes to weight-loss drugs.
A look at this week's movers and shakers.
The bigger they are, the harder they (might) fall.
Are These Dividends Too Good to Be True?
Lots of high-yielding stocks won't last.
A month into an acquisition, and Merck already sees a benefit.
4-Star Stocks Poised to Pop: Merck
Market-trouncing returns could be written in these four stars.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK